Login / Signup

Total serum IgA levels and HLA-DQB1*02:01 allelic status.

Diyora AbdukhakimovaMalika IbrayevaKuanysh DossybayevaAida TurganbekovaZhuldyz ZhanzakovaSaniya AbdrakhmanovaPauline McLooneDimitri Poddighe
Published in: Immunologic research (2023)
Immunoglobulin A Deficiency (IgAD) is the most common primary immunodeficiency and is significantly associated with Celiac Disease (CD), which recognizes a specific background of human leukocyte antigens (HLA) predisposition (including HLA-DQB1*02:01 allele). A number of studies investigated the role of HLA in IgAD etiopathogenesis: HLA-DQB1*02 alleles are included in the main haplotypes linked to this primary immunodeficiency. In this preliminary study, we investigated the potential impact of HLA-DQB1*02:01 allelic status on total serum IgA levels: 108 serum samples from the bone marrow donors' registry were analyzed for total IgA concentration with respect to the HLA-DQB1*02:01 status. Although total serum IgA levels between HLA-DQB1*02:01 carriers and HLA-DQB1*02:01 negative donors were not different, we observed a statistically significant difference (p=0.0118) in total serum IgA levels among donors with low IgA concentration (<80mg/dL) in the sub-analysis between HLA-DQB1*02:01 positive group (including both homozygous and heterozygous carriers) compared to HLA-DQB1*02:01 negative donors. Our results might suggest a role of HLA-DQB1*02:01 allelic variant in the determination of total serum IgA levels, at least in patients affected with IgA deficiency and/or otherwise predisposed to it; however, larger and more standardized studies are needed to confirm this speculation.
Keyphrases
  • bone marrow
  • end stage renal disease
  • chronic kidney disease
  • celiac disease
  • immune response
  • mesenchymal stem cells
  • kidney transplantation
  • ejection fraction
  • peripheral blood
  • replacement therapy
  • single molecule